In terms of TNFRSF18, it is inactivated during tumor progression in Multiple Myeloma (MM) through promoter CpG island methylation, leading to gene silencing in primary MM cells and MM cell lines75. The gene discussed is TNFRSF18; the disease is neoplasm.